동의신경정신과학회지 (Journal of Oriental Neuropsychiatry)

  • 제34권1호
  • /
  • Pages.1-12
  • /
  • 2023
  • /
  • 1226-6396(pISSN)
  • /
  • 2234-4942(eISSN)
대한한방신경정신과학회 (The Korean Society of Oriental Neuropsychiatry)
권호 표지
DOI QR코드

DOI QR Code

우울증 환자 진료를 위한 한의표준임상경로 개발 연구

Developing a Clinical Pathway of Korean Medicine for Managing Patients with Depression

  • 권도형 (경희대학교 일반대학원 임상한의학과) ;
  • 김윤나 (경희대학교 일반대학원 임상한의학과) ;
  • 이승호 (경희대학교 일반대학원 임상한의학과) ;
  • 조성훈 (경희대학교 한의과대학)
  • Dohyung Kwon (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Yunna Kim (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Seung-Ho Lee (Department of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Seung-Hun Cho (Department of College of Korean Medicine, Kyung Hee University)
  • 투고 : 2023.03.02
  • 심사 : 2023.03.22
  • 발행 : 2023.03.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: To standardize treatment, improve quality of medical service, and reduce medical costs of patients with depression by developing a clinical pathway (CP) of Korean medicine. Methods: CP was developed based on clinical practice guideline (CPG) for depression. To consider the degree of economic burden and satisfaction, the current status of management for patients with depression was examined. After CP was primarily developed, contents of the CP were supplemented by referring to previously developed CPs. Results: Based on CPG, current status survey and previous CP, four types of CP (Korean medicine clinics, Korean medicine hospitals, Western-Korean medicine collaborative hospitals, public medical center) were developed and shown in the algorithm version. However, in the case of Korean medicine hospitals and Western-Korean medicine collaborative hospitals, CPs were detailed according to different clinical scenes of outpatients and inpatients. This study also shows six different time task matrix version. Conclusions: CP for depression is expected to not only reduce financial burden of patients and health insurance, but also increase the quality of treatment and satisfaction.

키워드

과제정보

This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea(grant number : HF21C0036).

참고문헌

  1. Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, Stein DJ, Zaslavsky AM, Aguilar-Gaxiola S, Alonso J, Andrade L, Benjet C, de Girolamo G, de Graaf R, Demyttenaere K, Fayyad J, Haro JM, Hu Cy, Karam A, Lee S, Lepine JP, Matchsinger H, Mihaescu-Pintia C, Posada-Villa J, Sagar R, Ustun TB. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Archives of General Psychiatry. 2011;68:90-100. https://doi.org/10.1001/archgenpsychiatry.2010.180
  2. Adler DA, McLaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D. Job Performance deficits due to depression. The American Journal of Psychiatry. 2006;163:1569-76. https://doi.org/10.1176/appi.ajp.163.9.1569
  3. World Health Organization. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. 2011.
  4. Solomon DA, Keller MB, Leon AC, Mueller TI, Lavori PW, Shea MT, Coryell W, Warshaw M, Turvey C, Maser JD, Endicott J. Multiple Recurrences of Major Depressive Disorder. The American Journal of Psychiatry. 2000;157:229.
  5. Song KY, Kim SN, Park JH. Critical pathway for operable gastric cancer. Journal of Korean Gastric Cancer Association. 1995;5:95-100. https://doi.org/10.5230/jkgca.2005.5.2.95
  6. Pearson SD, Goulart-Fisher D, Lee TH. Critical pathways as a strategy for improving care: problems and potential. Annals of Internal Medicine. 1995;123:941-8. https://doi.org/10.7326/0003-4819-123-12-199512150-00008
  7. Yoon SD, Song MY, Chung WS, Kim HS, Shin WC, Kim TO, Cho WS, Seo YH, Seo SW, Seo JW, Kang JH, Yu SH, Kim SY, Cho JH. A study on the development of a clinical pathway of Korean medicine for the management of patients with ankle sprain. Journal of Korean Medicine Rehabilitation. 2022;32:141-51. https://doi.org/10.18325/jkmr.2022.32.3.141
  8. Choi SJ, Kim DI, Noh EJ. A study on the application of standard korean medicine clinical pathway for dysmenorrhea. The Jorunal of Oriental Obstetrics & Gynecology. 2022;35:75-90.
  9. Lee HH, Shim SB, Lee HL. A survey on public perception of Korean medical treatment for the development of Korean medicine clinical practice guideline and critical pathway for growth disorders. The Journal of Pediatrics of Korean Medicine. 2022:36;65-77.
  10. Kim EH, Kim CK, Lee SK, Park SK. Development of a clinical pathway for gastrectomy and effect of its implementation in one tertiary hospital. Quality Improvement in Health Care. 2003;10:76-89.
  11. Chang YS, Lee SH, Lee SM, Hong SW. Development and implementation of critical pathway for patients undergoing laparoscopic cholecystectomy. Jorunal of the Korean Society of Endoscopic & Laparoscopic Surgeons. 2005;8:66-71.
  12. Segal O, Bellemans J, Van Gerven E, Deneckere S, Panella M, Sermeus W, et al. Important variations in the content of care pathway documents for total knee arthroplasty may lead to quality and patient safety problems. Journal of Evaluation in Clinical Practice. 2013;19:11-5. https://doi.org/10.1111/j.1365-2753.2011.01760.x
  13. Coffey RJ, Richards JS, Remmert CS, LeRoy SS, Schoville RR, Baldwin PJ. An introduction to critical paths. Quality Management in Healthcare. 2005;10:2:76-89.
  14. Eom YJ, Kwon DH, Kim YN, Lee HW, Chung SY, Cho SH. A pilot study on effects of critical pathway application for Hwa-Byung. Journal of Oriental Neuropsychiatry. 2021;32:337-43. https://doi.org/10.7231/JON.2021.32.4.337
  15. Sung DM, Choi SY, Park MJ, Sung SH. A study on the characteristics of the awareness and satisfication level of musculoskeletal patients and non-musculoskeletal patients that use Korean Medical institutions. Journal of Society of Preventive Korean Medicine. 2020;24:27-38. https://doi.org/10.3904/kjm.2020.95.1.27
  16. Bloom DE, Chen S, Kuhn M, McGovern ME, Oxley L, Prettner K. The economic burden of chronic diseases: Estimate and projections for China, Japan, and South Korea. The Journal of the Economics of Ageing. 2020;17:100163.
  17. Murray CJ, Lopez AD, Organization WH. The global burden of disease: a comprehensive assesment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summar. World Health Organization. 1996.
  18. Rotter T, Kinsman L, Jame E, Machotta A, Gothe H, Willis J, Snow P, Kugler J. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev. 2010;3:CD006632.
  19. Rotter T, deJong RB, Lacko SE, Ronellenfitsch U, Kinsman L. Clinical pathways as a quality strategy. Improving Healthcare Quality in Europe. Copenhagen:OECD Publishing. 2019;309.